≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Testicular dysfunction, other/unspecified

DOID EFO Endpoint Browser PheWeb

E4_TESTICDYSNAS

testicular disease: A non-neoplastic or neoplastic disorder affecting the testis. Representative examples include torsion, infarction, germ cell tumor, sex cord-stromal tumor, lymphoma, and leukemia.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

only males

226725

2. Check conditions

None

226725

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E29.8, E29.9
  • Hospital discharge: ICD-9 — 257[8-9]
  • Hospital discharge: ICD-8 — 2579
  • Cause of death: ICD-10 — E29.8, E29.9
  • Cause of death: ICD-9 — 257[8-9]
  • Cause of death: ICD-8 — 2579

2 out of 7 registries used, show all original rules.

206

4. Check minimum number of events

None

206

5. Include endpoints

None

206

6. Filter based on genotype QC (FinnGen only)

199

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1111 - 1111
Only index persons 1058 - 1058
Unadjusted period prevalence (%)
Whole population 0.03 - 0.03
Only index persons 0.04 - 0.04
Median age at first event (years)
Whole population - - 39.11
Only index persons - - 39.11

-FinnGen-

Key figures

All Female Male
Number of individuals 199 - 199
Unadjusted period prevalence (%) 0.09 - 0.09
Median age at first event (years) 51.48 - 51.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
206
Matched controls
2060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
54.9
191.9
135
69
E29.9
ICD-10 Finland
Testicular dysfunction, unspecified
2114.5
169.3
141
*
E29.1
ICD-10 Finland
Testicular hypofunction
38.5
77.5
50
17
E29.8
ICD-10 Finland
Other testicular dysfunction
+∞
73.4
66
*
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
38.6
67.2
43
14
A55
ICPC
General and Unspecified, Local injection/infiltration
45.9
23.3
28
7
101
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
20.1
19
*
A50
ICPC
General and Unspecified, Medication/prescr/renewal
9.2
20.1
26
32
121
Kela drug reimbursment
Severe hypofunction of sexual glands
184.3
16.8
17
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
6.3
16.1
29
52
WVA30, ,
SPAT
5.8
14.6
29
57
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
+∞
11.6
11
*
G47.3
ICD-10 Finland
Sleep apnoea
2.8
11.1
86
425
Y28
ICPC
Limited function/disability (Y)
45.9
11.1
13
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
9.3
9.0
18
21
N02AX02
ATC
tramadol; systemic, rectal
2.3
8.0
104
630
R53
ICD-10 Finland
Malaise and fatigue
2.5
7.5
57
272
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.7
6.8
41
174
N03AX16
ATC
[U] pregabalin
2.4
6.6
51
244
G03GA01
ATC
chorionic gonadotrophin; parenteral
72.0
6.5
7
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
4.1
6.4
18
47
-50
ICPC
Medication/prescr/renewal
7.4
6.3
14
20
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.3
6.1
60
318

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Proper column names.
  • Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV not working.
  • No filters and sorters.
  • Limited amount of endpoints with TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Testicular dysfunction, unspecified
E29.9 (45552393)
Other testicular dysfunction
E29.8 (45586155)
General Practice
1 (38004446)
Body height measure
50373000 (4177340)
Body mass index
60621009 (4245997)
Ultrasound examination of scrotum
KF8AE (2001306187)
tadalafil; oral
G04BE08 (21602653)
Lutropin [Units/volume] in Serum or Plasma
10501-5 (3009214)
General Surgery
2 (38004447)
Urology
34 (38004474)
Endocrinology
46 (38004485)
Hyperplasia of prostate
N40 (45563015)
Reproductive Endocrinology / Infertility
OMOP4822013 (45756826)
Emergency Room Visit
ER (9203)
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 (21602510)
Testosterone [Moles/volume] in Serum or Plasma
14913-8 (3017446)
androstanolone
A14AA01 (21600917)
androstanolone
G03BB02 (21602513)
Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13967-5 (3004248)
Testosterone Free [Moles/volume] in Serum or Plasma by calculation
96559-0 (36032269)
Pharmacy visit
OMOP4822462 (581458)
Case Management Agency
251B00000X (38004193)
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12841-3 (3001784)
Outpatient Visit
OP (9202)
Prostate specific Ag [Mass/volume] in Serum or Plasma
2857-1 (3013603)
CBC panel - Blood by Automated count
58410-2 (40761511)
sildenafil; oral
G04BE03 (21602648)
Sleep apnoea
G47.3 (45562094)
Laboratory Visit
OMOP4822461 (32036)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
Platelets [#/volume] in Blood
26515-7 (3007461)
MCH [Entitic mass]
28539-5 (3035941)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
Supplier / Service Provider
OMOP5117446 (33004)
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 (3009201)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
74
70
15.94
72.46
2.1
1.6
5.69
4.88
u/l
0.40
63
57
151
394
11.61
66.03
6.4
2.2
13.48
15.41
nmol/l
2.63
151
374
172
1064
4.74
17.40
4.7
4.3
1.36
1.60
ug/l
1.27
165
970
26
46
6.32
14.54
2.3
1.3
183.48
173.80
pmol/l
0.16
26
46
118
636
3.00
13.50
3.1
2.7
0.64
0.72
ug/l
0.54
59
338
191
1471
5.10
10.13
5.0
3.9
1.82
1.91
mu/l
0.62
185
1369
30
82
4.11
10.13
1.7
1.3
—
—
—
0
0
77
410
2.40
8.01
2.8
5.5
—
—
—
0
0
101
613
2.27
7.66
2.0
1.9
92.31
94.54
pmol/l
0.21
61
335
113
723
2.25
7.49
6.0
9.6
1.21
1.20
mmol/l
1.77
99
643
45
195
2.67
7.14
2.1
1.7
3.42
3.61
mmol/l
0.44
35
132
127
892
2.11
6.18
4.4
3.4
—
7.08
—
0
13
124
867
2.08
6.07
6.0
7.3
0.59
0.60
e9/l
0.20
112
751
163
1272
2.35
5.93
8.7
9.1
75.15
79.03
u/l
0.43
157
1233
126
896
2.05
5.77
6.1
7.8
0.18
0.20
e9/l
0.93
114
793
123
868
2.04
5.74
6.0
7.4
0.04
0.04
e9/l
0.02
112
754
134
980
2.05
5.61
5.6
6.8
6.59
6.86
mmol/l
0.74
128
947
124
884
2.01
5.55
6.0
7.5
1.78
1.86
e9/l
0.53
113
786
11
15
7.68
5.21
1.3
1.1
19.94
26.93
ng/l
0.37
11
15
80
506
1.95
4.92
4.0
2.9
60.00
58.07
e6/l
0.01
65
376
60
347
2.03
4.73
1.3
1.4
2.48
2.65
g/l
0.42
43
243
177
1482
2.38
4.65
18.6
17.7
13.43
13.35
%
0.40
177
1469
56
321
2.02
4.51
2.4
2.2
2.57
2.93
mg/l
0.68
51
282
62
369
1.97
4.49
1.8
1.5
17.91
19.09
nmol/l
0.32
57
323
70
437
1.91
4.39
3.6
4.3
7.39
7.40
ph
0.83
50
305
62
374
1.94
4.30
1.2
1.4
0.66
0.84
u/ml
1.09
17
116
116
870
1.76
3.86
3.7
2.9
—
—
—
0
0
24
103
2.51
3.84
3.4
3.0
—
—
—
0
0
198
1813
3.37
3.75
16.7
12.3
—
—
—
0
0
124
956
1.75
3.67
8.9
11.2
4.27
4.17
e9/l
0.12
115
838
95
685
1.72
3.54
4.9
5.9
37.76
36.88
g/l
0.78
89
654
102
750
1.71
3.54
8.9
12.4
1.15
1.21
inr
0.46
78
629
110
833
1.69
3.37
3.6
3.1
0.00
0.00
estimate
-0.00
25
168
82
574
1.71
3.37
4.4
3.5
20.78
168.72
e6/l
1.20
67
405
19
78
2.58
3.32
1.3
1.2
33.02
134.57
u/ml
—
6
30
192
1727
2.64
3.27
19.1
14.1
25.20
24.29
mg/l
0.14
156
1405
69
466
1.72
3.20
2.7
2.6
396.83
371.69
umol/l
1.12
63
415
92
672
1.67
3.18
2.6
2.9
—
—
estimate
—
0
0
90
656
1.66
3.13
3.4
3.0
0.00
0.00
estimate
-0.00
24
146
77
541
1.68
3.07
3.9
4.7
6.10
9.45
mg/mmol
0.70
52
383
31
164
2.05
3.06
3.1
3.9
1.75
1.67
mmol/l
0.04
26
146
110
849
1.63
3.02
3.6
3.1
0.00
0.02
estimate
0.50
23
145
75
528
1.66
2.94
3.4
4.0
51.37
53.40
mg/l
0.04
50
376
109
844
1.62
2.92
3.7
3.1
0.00
0.00
estimate
-0.00
25
164
54
349
1.74
2.90
3.9
2.3
1.30
2.08
e6/l
1.42
54
311
85
621
1.63
2.87
5.4
3.8
9.65
9.11
mmol/l
0.41
77
553
65
447
1.66
2.77
3.8
2.8
0.35
0.43
e6/l
0.10
48
317
64
439
1.66
2.75
4.2
3.2
0.00
0.01
estimate
0.50
25
152
88
656
1.60
2.70
6.1
8.9
1.21
1.20
mmol/l
0.30
81
620
19
87
2.30
2.67
1.3
1.2
—
—
—
0
0
54
359
1.68
2.60
1.9
1.7
0.86
1.64
mg/l
1.52
44
270
182
1634
1.98
2.58
5.2
4.7
6.09
6.03
mmol/l
0.18
171
1534
66
466
1.61
2.50
3.8
3.3
2.35
2.34
mmol/l
0.27
59
427
30
169
1.91
2.49
3.2
4.2
7.39
7.38
ph
0.36
18
95
87
660
1.55
2.41
6.2
3.3
21.19
41.25
ng/l
1.69
63
431
10
35
2.95
2.24
1.2
1.2
3.71
3.82
mmol/l
—
10
35
37
231
1.73
2.22
2.9
3.2
151.13
119.66
ug/g
0.18
29
194
192
1776
2.19
2.19
6.2
4.9
1.21
1.28
mmol/l
2.48
186
1687
67
490
1.54
2.15
2.8
2.7
0.00
0.00
estimate
-0.00
22
132
161
1420
1.61
2.12
4.1
3.8
54.00
54.84
u/l
0.05
155
1359
15
69
2.27
2.10
1.3
1.5
—
—
—
0
0
69
520
1.49
1.90
1.9
2.0
—
—
—
0
0
186
1717
1.86
1.89
5.5
4.2
1.51
1.41
mmol/l
0.88
178
1628
95
763
1.45
1.89
12.0
11.0
0.00
0.00
e9/l
1.69
83
631
5
12
4.24
1.83
1.2
4.4
—
—
—
0
0
87
691
1.45
1.82
3.4
2.9
6.13
6.08
ph
0.19
59
416
8
29
2.83
1.81
1.1
1.5
—
—
—
0
0
16
81
2.06
1.80
1.9
5.1
94.96
95.08
ng/l
0.00
16
75
52
373
1.53
1.79
2.2
1.9
—
—
—
0
0
32
204
1.67
1.79
2.0
1.6
—
—
—
0
0
48
340
1.54
1.75
3.7
3.8
4155.16
462.32
ng/l
0.43
37
265
53
384
1.51
1.74
4.9
3.3
1.02
1.02
kg/l
0.39
35
245
21
119
1.85
1.74
1.0
1.2
—
—
—
0
0
21
121
1.82
1.66
2.1
1.9
0.00
0.00
estimate
—
5
32
91
739
1.41
1.65
1.7
2.1
1.62
1.50
mmol/l
0.56
77
633
8
33
2.48
1.55
1.1
1.8
—
—
—
0
0
37
254
1.56
1.55
3.0
2.7
0.25
0.52
e6/l
0.61
17
118
12
58
2.14
1.52
1.9
2.0
—
—
—
0
0
62
478
1.42
1.48
2.3
2.6
—
—
—
0
0
18
103
1.82
1.46
21.9
2.9
—
—
—
0
0
61
470
1.42
1.46
5.5
4.5
—
—
—
0
0
23
143
1.68
1.42
2.3
1.8
0.24
0.34
mg/l
0.48
15
70
28
188
1.57
1.30
1.6
1.5
—
—
—
0
0
8
36
2.27
1.25
2.3
3.1
—
—
—
0
0
23
149
1.61
1.23
1.1
1.0
—
—
—
0
0
25
167
1.57
1.19
3.9
8.2
10.00
7.99
mmol/l
0.88
25
161
34
246
1.46
1.13
1.2
1.2
9.97
24.92
iu/ml
—
9
61
30
214
1.47
1.07
2.7
1.7
—
—
—
0
0
23
155
1.54
1.06
6.4
2.1
—
—
—
0
0
23
155
1.54
1.06
6.3
2.1
—
—
—
0
0
23
155
1.54
1.06
6.4
2.1
—
—
—
0
0
23
155
1.54
1.06
6.3
2.1
—
—
—
0
0
18
116
1.60
1.00
2.8
3.3
—
—
—
0
0
0
29
0.00
0.98
0.0
22.6
—
1271.07
—
0
29
10
54
1.90
0.98
9.7
3.6
—
—
—
0
0
6
119
0.49
0.97
1.0
1.1
1.29
1.43
g/l
—
6
119
21
142
1.53
0.97
6.8
2.2
—
—
—
0
0
27
193
1.46
0.96
1.3
1.3
—
—
—
0
0
6
29
2.10
0.90
1.2
1.0
—
—
—
0
0
32
240
1.39
0.89
2.9
2.7
—
—
—
0
0
15
96
1.61
0.87
1.6
2.6
—
—
—
0
0
10
57
1.79
0.85
9.2
12.7
—
—
—
0
0
56
463
1.29
0.83
1.4
1.3
—
—
—
0
0
16
107
1.54
0.79
3.1
4.4
7.37
7.36
ph
0.18
11
87
32
247
1.35
0.76
7.9
11.1
104.91
104.30
mmol/l
0.44
32
247
65
554
1.25
0.75
6.1
7.3
—
—
—
0
0
5
24
2.11
0.75
1.8
3.6
6.96
7.27
pmol/l
—
5
24
7
38
1.87
0.74
1.1
2.8
8.00
8.23
kpa
—
7
38
19
135
1.45
0.72
2.0
1.9
—
—
—
0
0
29
223
1.35
0.71
1.3
1.4
235.00
309.77
titre
—
8
43
7
119
0.57
0.70
1.1
1.1
0.97
0.93
g/l
—
7
119
10
61
1.67
0.70
4.0
2.5
—
—
—
0
0
7
42
1.69
0.69
1.3
1.2
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
34
273
1.29
0.63
1.6
1.4
—
—
—
0
0
22
167
1.36
0.60
5.8
14.5
—
—
—
0
0
6
36
1.69
0.57
2.7
2.5
2.25
2.15
mmol/l
—
6
23
6
37
1.64
0.56
1.5
1.1
—
—
—
0
0
12
82
1.49
0.55
1.0
1.2
—
—
—
0
0
16
117
1.40
0.54
1.6
1.4
—
—
—
0
0
15
109
1.41
0.52
5.1
9.0
—
—
—
0
0
34
281
1.25
0.52
1.8
1.6
—
—
—
0
0
26
209
1.28
0.49
1.3
1.2
1.26
5.10
u/ml
1.07
18
85
33
277
1.23
0.45
1.4
1.8
—
—
—
0
0
5
32
1.58
0.42
1.0
1.3
—
—
—
0
0
22
179
1.26
0.39
1.4
1.2
—
—
—
0
0
12
91
1.34
0.34
1.4
1.2
—
—
—
0
0
6
45
1.34
0.34
2.0
1.8
—
—
—
0
0
23
197
1.19
0.27
1.4
1.7
—
—
—
0
0
22
189
1.18
0.25
7.9
16.3
95.68
95.86
%
0.10
22
182
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
5.4
—
2.70
—
0
11
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
2214.50
—
0
10
5
43
1.17
0.21
1.4
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.8
—
0.69
—
0
13
9
111
0.80
0.20
5.1
18.7
16.80
16.38
%
—
9
105
53
494
1.10
0.20
9.5
5.7
—
—
—
0
0
6
50
1.21
0.20
1.3
1.1
—
—
—
0
0
13
110
1.19
0.17
11.7
12.0
26.44
24.21
mmol/l
2.12
13
103
5
70
0.71
0.17
1.2
1.1
—
—
—
0
0
14
162
0.85
0.17
1.7
2.9
0.21
0.24
g/l
0.63
14
151
28
256
1.11
0.15
2.6
2.2
—
—
—
0
0
7
90
0.77
0.14
2.0
2.8
—
—
—
0
0
11
94
1.18
0.13
4.5
3.0
0.52
0.63
%
0.58
11
94
5
60
0.83
0.08
1.6
1.2
—
—
—
0
0
5
60
0.83
0.08
1.6
1.1
—
—
—
0
0
22
206
1.08
0.07
1.9
1.7
1081.37
1228.55
nmol/l
0.29
14
163
22
206
1.08
0.07
7.7
15.4
7.44
7.42
ph
0.68
13
105
19
184
1.04
0.00
8.2
16.7
130.95
125.71
g/l
0.42
19
178
24
242
0.99
0.00
1.3
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
8.97
—
0
8
0
8
0.00
0.00
0.0
1.1
—
0.00
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
2.02
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
10.20
—
0
5
0
5
0.00
-0.00
0.0
3.0
—
53.80
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.6
—
27.20
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
112.40
—
0
5
0
9
0.00
-0.00
0.0
1.8
—
2.44
—
0
9
0
6
0.00
-0.00
0.0
2.2
—
7.27
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
26.03
—
0
7
0
6
0.00
-0.00
0.0
2.7
—
333.50
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
14.40
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
0.46
—
0
7
6
69
0.87
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
14.87
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint E4_TESTICDYSNAS and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
E4_TESTICDYSNAS 1.564 [1.05, 2.32] 0.026
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 694 males with E4_TESTICDYSNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_TESTICDYSNAS.

N-year risk Females Males
1 No data 0.294%
5 No data 1.847%
10 No data 4.324%
15 No data 8.11%
20 No data 13.644%

Relationships between endpoints

↥

Index endpoint: E4_TESTICDYSNAS – Testicular dysfunction, other/unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data